Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Yasumasa, Higuchi, Makoto, Zhang, Bin, Huang, Shu-Ming, Iwata, Nobuhisa, Saido, Takaomi C., Maeda, Jun, Suhara, Tetsuya +2 more·2007·Neuron
DOI 10.1016/j.neuron.2007.01.010

Cited by (1,029)

Items 701–800 of 1,029

  1. Tau expression levels from various adeno‐associated virus vector serotypes produce graded neurodegenerative disease states
    Ronald L. Klein, Robert D. Dayton, Jason B Tatom, Cynthia G. Diaczynsky, Michael F. Salvatore · 2008 · European Journal of Neuroscience
  2. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis
    Christoph N. Köhler, Maja Dinekov, Jürgen Götz · 2014 · Neurobiology of Disease
  3. Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
    Rudy J. Castellani, Xiongwei Zhu, Hyoung‐gon Lee, Mark A. Smith, George L. Perry · 2009 · International Journal of Molecular Sciences
  4. Age-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticles
    Micaela Johanna Glat, Hadas Skaat, Noa Menkes-Caspi, Shlomo Margel, Edward A Stern · 2013 · Journal of Nanobiotechnology
  5. Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate
    Marie K. Bondulich, Tong Guo, Christopher Meehan, John Manion, T. Rodriguez Martin, Jacqueline C. Mitchell, Tibor Hortobágyi, Natalia Yankova, Virginie Stygelbout, Jean‐Pierre Brion et al. · 2016 · Brain
  6. Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability
    Jacques P. Mayeux, Paige S. Katz, Scott Edwards, Jason W. Middleton, Patricia E. Molina · 2016 · Journal of Neurotrauma
  7. Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction
    Chris Moran, Richard J Beare, Thanh G. Phan, SERGIO E. STARKSTEIN, David G. Bruce, Romina Mizrahi, Velandai K. Srikanth · 2017 · Journal of Alzheimer s Disease
  8. β-Amyloid oligomers in aging and Alzheimer’s disease
    Kathleen R. Zahs, Karen H. Ashe · 2013 · Frontiers in Aging Neuroscience
  9. Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: Characterization of a novel model and systematic review of the literature
    Kahriman, Aydan, Bouley, James, Smith, Thomas W., Bosco, Daryl A., Woerman, Amanda L., Henninger, Nils · 2021 · Acta Neuropathologica Communications
  10. Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer's disease
    Diane Chan, Ho‐Jun Suk, Brennan Jackson, Noah Milman, Danielle Stark, Sara D. Beach, Li‐Huei Tsai · 2021 · Journal of Internal Medicine
  11. Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
    Avital Licht-Murava, Samantha M. Meadows, Fernando Palaguachi, Soomin C. Song, Yaron Bram, Constance Q. Zhou, Stephanie Jackvony, Robert E. Schwartz, Robert C. Froemke, Adam L. Orr et al. · 2023 · Science Advances
  12. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
    Anastasie Maté de Gérando, Lindsay A. Welikovitch, Anita Khasnavis, Caitlin Commins, Calina A. Glynn, Joshua E Chun, Romain Perbet, Bradley T. Hyman · 2023 · Acta Neuropathologica
  13. Dendritic Spine Abnormalities in Hippocampal CA1 Pyramidal Neurons Underlying Memory Deficits in the SAMP8 Mouse Model of Alzheimer's Disease
    Jaume del Valle, Sergi Bayod, Antoni Camins, Carlos Beas‐Zárate, Dulce A. Velázquez-Zamora, Ignacio González‐Burgos, Mercè Pallàs · 2012 · Journal of Alzheimer s Disease
  14. Proteasome–caspase–cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells
    Lisette T. Arnaud, Natura Myeku, Maria E. Figueiredo‐Pereira · 2009 · Journal of Neurochemistry
  15. A novel function for pro SAAS as an amyloid anti‐aggregant in Alzheimer's disease
    Akina Hoshino, Michael Helwig, Sina Rezaei, Casey Berridge, Jason L. Eriksen, Iris Lindberg · 2013 · Journal of Neurochemistry
  16. Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model
    Anat Idan-Feldman, Yulie Schirer, Eleni Polyzoidou, Olga Touloumi, Roza Lagoudaki, Nikolaos Grigoriadis, Illana Gozes · 2011 · Neurobiology of Disease
  17. Tauopathy models and human neuropathology: similarities and differences
    S. Frank, F. Clavaguera, M. Tolnay · 2007 · Acta Neuropathologica
  18. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation
    Eunhee Kim, Kazuko Sakata, Francesca‐Fang Liao · 2017 · PLoS Genetics
  19. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils
    Gibbons, Garrett S., Banks, Rachel A., Kim, Bumjin, Xu, Hong, Changolkar, Lakshmi, Leight, Susan N., Riddle, Dawn M., Li, Chi, Gathagan, Ronald J., Brown, Hannah J. et al. · 2017 · The Journal of Neuroscience
  20. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice
    Marangelie Criado‐Marrero, Niat T. Gebru, Danielle M. Blazier, Lauren A. Gould, Jeremy D. Baker, David Beaulieu‐Abdelahad, Laura J. Blair · 2021 · Acta Neuropathologica Communications
  21. Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
    Rakez Kayed, George R. Jackson · 2009 · Current Opinion in Immunology
  22. Reduction of the immunostainable length of the hippocampal dentate granule cells’ primary cilia in 3xAD-transgenic mice producing human Aβ1-42 and tau
    Chakravarthy, Balu, Gaudet, Chantal, Ménard, Michel, Brown, Leslie, Atkinson, Trevor, LaFerla, Frank M., Ito, Shingo, Armato, Ubaldo, Dal Prà, Ilaria, Whitfield, James · 2012 · Biochemical and Biophysical Research Communications
  23. Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology
    Magisetty Obulesu, R. Venu, R. Somashekhar · 2011 · Neurochemical Research
  24. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration
    Valeria Melis, Claudia Zabke, Karsten Stamer, Mandy Magbagbeolu, Karima Schwab, P. Marschall, Rüdiger W. Veh, Sarah Bachmann, Serena Deiana, Pierre‐Henri Moreau et al. · 2014 · Cellular and Molecular Life Sciences
  25. Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model
    Yasumasa Yoshiyama, Ayako Kojima, Kimiko Itoh, Tomoyuki Uchiyama, Kimihito Arai · 2011 · Neurobiology of Disease
  26. Increased tauopathy drives microglia-mediated clearance of beta-amyloid
    Wesley Chen, Edsel Abud, Stephen T. Yeung, Anita Lakatos, Trevor Nassi, Jane Wang, David L Blum, Luc Buée, Wayne W. Poon, Mathew M. Blurton-Jones · 2016 · Acta Neuropathologica Communications
  27. Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies
    Fulvio Florenzano, Veronica Corsetti, Gabriele Ciasca, Maria Teresa Ciotti, Anna Pittaluga, Guendalina Olivero, Marco Feligioni, Filomena Iannuzzi, Valentina Latina, Michele F. M. Sciacca et al. · 2017 · Oncotarget
  28. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
    Kevin H. Strang, Marshall S. Goodwin, Cara J. Riffe, Brenda D. Moore, Paramita Chakrabarty, Yona Levites, Todd Eliot Golde, Benoit I. Giasson · 2017 · Acta Neuropathologica Communications
  29. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy
    Jin Zheng, Mansour Akbari, Claire Schirmer, Marie‐Line Reynaert, Anne Loyens, Bruno Lefebvre, Luc Buée, Deborah L. Croteau, Marie‐Christine Galas, Vilhelm A. Bohr · 2020 · Acta Neuropathologica Communications
  30. Synaptic Loss in Frontotemporal Dementia Revealed by [ <scp> <sup>11</sup> C </scp> ] <scp>UCB‐J Positron Emission Tomography</scp>
    Malpetti, Maura, Jones, P. Simon, Cope, Thomas E., Holland, Negin, Naessens, Michelle, Rouse, Matthew A., Rittman, Timothy, Savulich, George, Whiteside, David J., Street, Duncan et al. · 2023 · Annals of Neurology
  31. A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals
    Peng Liu, Benjamin R. Smith, Michelle L. Montonye, Lisa J. Kemper, Kailee Leinonen-Wright, Kathryn M. Nelson, LeeAnn Higgins, Candace R. Guerrero, Todd W. Markowski, Xiaohui Zhao et al. · 2020 · Scientific Reports
  32. Porphyromonas gingivalis outer membrane vesicles in cerebral ventricles activate microglia in mice
    Kayo Yoshida, Kaya Yoshida, Mariko Seyama, Yuka Hiroshima, Mana Mekata, Natsumi Fujiwara, Yasusei Kudo, Kazumi Ozaki · 2022 · Oral Diseases
  33. Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing
    Lien D. Nguyen, Zhiyun Wei, M. Catarina Silva, Sergio Barberán-Soler, Jiarui Zhang, Rosalia Rabinovsky, Christina Muratore, Jonathan M. S. Stricker, Colin Hortman, Tracy L. Young‐Pearse et al. · 2023 · Nature Communications
  34. Vaccination as a Therapeutic Approach to Alzheimer's Disease
    Thomas Wısnıewskı, Allal Boutajangout · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  35. Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
    Vishruti S. Makani, Bin Zhang, Heeoon Han, Yuemang Yao, Pierrik Lassalas, Kevin Lou, Ian Paterson, Virginia M.‐Y. Lee, John Q. Trojanowski, Carlo Ballatore et al. · 2016 · Acta Neuropathologica Communications
  36. BDNF inhibits neurodegenerative disease–associated asparaginyl endopeptidase activity via phosphorylation by AKT
    Zhi-Hao Wang, Wanqiang Wu, Seong Su Kang, Xia Liu, Zhiping Wu, Junmin Peng, Shan Ping Yu, Fredric P. Manfredsson, Ivette M. Sandoval, Xuebo Liu et al. · 2018 · JCI Insight
  37. Spermidine/spermine-N1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response
    Leslie A. Sandusky‐Beltran, Andrii Kovalenko, Chao Ma, John Ivan T. Calahatian, Devon S. Placides, Mallory Watler, Jerry B. Hunt, April L. Darling, Jeremy D. Baker, Laura J. Blair et al. · 2019 · Alzheimer s Research & Therapy
  38. SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury
    Andrew D. Sauerbeck, Mihika Gangolli, Sydney J. Reitz, Maverick H. Salyards, Samuel Kim, Christopher Hemingway, Maud Gratuze, Tejaswi Makkapati, Martin Kerschensteiner, David M. Holtzman et al. · 2020 · Neuron
  39. Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration
    M. Al-Onaizi, Alaa B. Alkhalifah, Dalal Qasem, A. ElAli · 2020 · International Journal of Molecular Sciences
  40. Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
    Bittar, Alice, Sengupta, Urmi, Kayed, Rakez · 2018 · npj Vaccines
  41. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510)
    Yang, Dewen, Xie, Zhiyong, Stephenson, Diane, Morton, Daniel, Hicks, Carol D., Brown, Tracy M., Sriram, Renuka, O'Neill, Sharon, Raunig, David, Bocan, Thomas · 2011 · NeuroImage
  42. Neurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model
    Hideaki Sato, Yuhei Takado, Sakiko Toyoda, Masako Tsukamoto‐Yasui, Keiichiro Minatohara, Hiroyuki Takuwa, Takuya Urushihata, Manami Takahashi, Masafumi Shimojo, Maiko Ono et al. · 2021 · Science Advances
  43. Evolutionarily conserved regulators of tau identify targets for new therapies
    Jiyoen Kim, María de Haro, Ismael Al‐Ramahi, Lorena Laura Garaicoechea, Hyun-Hwan Jeong, Jun Young Sonn, Bakhos Tadros, Zhandong Liu, Juan Botas, Huda Yahya Zoghbi · 2023 · Neuron
  44. Accelerated Neurodegeneration and Neuroinflammation in Transgenic Mice Expressing P301L Tau Mutant and Tau-Tubulin Kinase 1
    Hirohide Asai, Seiko Ikezu, Maya E. Woodbury, Grant Yonemoto, Libin Cui, Tsuneya Ikezu · 2014 · American Journal Of Pathology
  45. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-Κb to Halt Alzheimer's Disease
    Uddin, Md. Sahab, Hasana, Sharifa, Ahmad, Jamil, Hossain, Md. Farhad, Rahman, Md. Mosiqur, Behl, Tapan, Rauf, Abdur, Ahmad, Ausaf, Hafeez, Abdul, Perveen, Asma et al. · 2021 · Current Pharmaceutical Design
  46. Novelty‐like activation of locus coeruleus protects against deleterious human pretangle tau effects while stress‐inducing activation worsens its effects
    Tamunotonye Omoluabi, Sarah E. Torraville, Aida Maziar, Abhinaba Ghosh, Kyron D. Power, Camila Reinhardt, Carolyn W. Harley, Qi Yuan · 2021 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  47. Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders
    Masahiro Ohgidani, Takahiro A. Kato, Shigenobu Kanba · 2015 · Frontiers in Cellular Neuroscience
  48. MRS in presymptomatic MAPT mutation carriers
    Kejal Kantarci, Bradley F. Boeve, Zbigniew K. Wszołek, Rosa Rademakers, Jennifer Louise Whitwell, Matthew Baker, Matthew L. Senjem, Ali R. Samikoglu, David S. Knopman, Ronald Carl Petersen et al. · 2010 · Neurology
  49. Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity
    Joungil Choi, Krish Chandrasekaran, Tyler G. Demarest, Tibor Kristián, Su Xu, Kadambari Vijaykumar, K.G. Dsouza, Nathan Qi, Paul Yarowsky, Rao Gallipoli et al. · 2014 · Annals of Clinical and Translational Neurology
  50. CHCHD10‐regulated OPA1‐mitofilin complex mediates TDP‐43‐induced mitochondrial phenotypes associated with frontotemporal dementia
    Tian Liu, Jung A. Woo, Mohammed Zaheen Bukhari, Patrick LePochat, Ann Chacko, Maj‐Linda B. Selenica, Yan Yan, Peter Kotsiviras, Sara Cazzaro, Xingyu Zhao et al. · 2020 · The FASEB Journal
  51. Alzheimer's disease: Old problem, new views from transgenic and viral models
    Tomasz Jaworski, Ilse Dewachter, Claire Marie Seymour, Peter Borghgraef, Herman Devijver, Sebastian Kügler, Fred VAN LEUVEN · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  52. Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells
    Wang, Lu, Jiang, Qian, Chu, Jiang, Lin, Li, Li, Xiao-Guang, Chai, Gao-Shang, Wang, Qun, Wang, Jian-Zhi, Tian, Qing · 2013 · PLoS ONE
  53. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
    Yin, Xiaomin, Qiu, Yanyan, Zhao, Chenhao, Zhou, Zheng, Bao, Junze, Qian, Wei · 2021 · Medical Science Monitor
  54. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer’s disease
    Stancu, Ilie‐Cosmin, Ris, Laurence, Vasconcelos, Bruno, Marinangeli, Claudia, Goeminne, Léonie, Laporte, Vincent, Haylani, Laetitia E., Couturier, Julien, Schakman, Olivier, Gailly, Philippe et al. · 2014 · The FASEB Journal
  55. Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?
    Yuetiva K. Deming, Zeran Li, Bruno A. Benítez, Carlos Cruchaga · 2018 · Expert Opinion on Therapeutic Targets
  56. Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
    Md. Sahab Uddin, Md. Tanvir Kabir · 2019 · Springer eBooks
  57. Phosphoproteomics identifies microglial Siglec‐F inflammatory response during neurodegeneration
    Nader Morshed, William T. Ralvenius, Alexi Nott, Lauren Ashley Watson, Felicia H. Rodriguez, Leyla Anne Akay, Brian A. Joughin, Ping‐Chieh Pao, Jay Penney, Lauren M. LaRocque et al. · 2020 · Molecular Systems Biology
  58. Early detection of Alzheimer's disease using creatine chemical exchange saturation transfer magnetic resonance imaging
    Lin Chen, Peter C.M. van Zijl, Zhiliang Wei, Hanzhang Lu, Wenzhen Duan, Philip C. Wong, Tong Li, Jiadi Xu · 2021 · NeuroImage
  59. Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease
    Sivaprakasam R. Saroja, Abhijeet Sharma, Patrick R. Hof, Ana C. Pereira · 2021 · Alzheimer s & Dementia
  60. The Functions and Phenotypes of Microglia in Alzheimer’s Disease
    Risako Fujikawa, Makoto Tsuda · 2023 · Cells
  61. Central Nervous System Macrophages in Health and Disease
    Hannah Van Hove, Donatella De Feo, Melanie Greter, Burkhard Becher · 2025 · Annual Review of Immunology
  62. Behavioral Improvement after Chronic Administration of Coenzyme Q10 in P301S Transgenic Mice
    Ceyhan Elipenahli, Cliona Stack, Shari Jainuddin, Meri Gerges, Lichuan Yang, Anatoly A. Starkov, M. Flint Beal, Magali Dumont · 2012 · Journal of Alzheimer s Disease
  63. Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: Implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression
    Shunsuke Koga, Ayako Kojima, Chieko Ishikawa, Satoshi Kuwabara, Kimihito Arai, Yasumasa Yoshiyama · 2014 · Neurobiology of Disease
  64. Opportunities and challenges in developing relevant animal models for Alzheimer’s disease
    Fernanda G. De Felice, Douglas P. Munoz · 2016 · Ageing Research Reviews
  65. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain
    Jeanna M. Wheeler, Pamela J. McMillan, Timothy J. Strovas, Nicole F. Liachko, Alexandre Amlie‐Wolf, Rebecca L. Kow, Ronald L. Klein, Patricia Szot, Linda Robinson, Chris R. Guthrie et al. · 2019 · Science Translational Medicine
  66. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
    Brendan B. McAllister, Sean G. Lacoursiere, Robert J. Sutherland, Majid H. Mohajerani · 2020 · Neuroscience & Biobehavioral Reviews
  67. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer’s Disease
    Jack Hashem, Mei Hu, Jian Zhang, Fei Gao, Chu Chen · 2021 · Molecular Neurobiology
  68. TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury
    Fei Gao, Mei Hu, Jian Zhang, Jack Hashem, Chu Chen · 2022 · Acta Neuropathologica
  69. NPT088 reduces both amyloid‐β and tau pathologies in transgenic mice
    Levenson, Jonathan M., Schroeter, Sally, Carroll, Jenna C., Cullen, Valerie, Asp, Eva, Proschitsky, Ming, Chung, Charlotte H.‐Y., Gilead, Sharon, Nadeem, Muhammad, Dodiya, Hemraj B. et al. · 2016 · Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions
  70. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
    Jarrah O.-Z.J. Kron, Ryan J. Keenan, Daniël Hoyer, Laura H. Jacobson · 2023 · The Annual Review of Pharmacology and Toxicology
  71. Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy
    Danira Toral-Ríos, Justin M. Long, Jason D. Ulrich, Jinsheng Yu, Michael R. Strickland, Xianlin Han, David M. Holtzman, Anil G. Cashikar, Steven M. Paul · 2024 · The Journal of Experimental Medicine
  72. Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
    Kerstin T.S. Wirz, Stella Keitel, Dick Frans Swaab, Joost Verhaagen, Koen Bossers · 2013 · Journal of Alzheimer s Disease
  73. Brief update on different roles of tau in neurodegeneration
    Arne Ittner, Yazi Diana Ke, Janet van Eersel, Amadeus Gladbach, Jürgen Götz, Lars Matthias Ittner · 2011 · IUBMB Life
  74. Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice
    Montasir Elahi, Zafrul Hasan, Yumiko Motoi, Shin‐ei Matsumoto, Koichi Ishiguro, Nobutaka Hattori · 2016 · Journal of Alzheimer s Disease
  75. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes
    Jung A. Woo, Tian Liu, Xingyu Zhao, Courtney Trotter, Ksenia Yrigoin, Sara Cazzaro, Emilio De Narvaez, Hirah Khan, Richard Witas, Anusha Bukhari et al. · 2017 · Human Molecular Genetics
  76. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons
    Yiren Qin, Yu Zhang, Inge Tomic, Wenlin Hao, Michael Dieter Menger, Chun‐Feng Liu, Klaus C Fassbender, Yang Liu · 2018 · Journal of Alzheimer s Disease
  77. Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice
    Leah K. Cuddy, Dmitry Prokopenko, Eric P. Cunningham, Ross Brimberry, Peter Song, Rory Kirchner, Brad Chapman, Oliver Hofmann, Winston Hide, Daniele Procissi et al. · 2020 · Science Translational Medicine
  78. Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease
    Supriya Ramesha, Sruti Rayaprolu, Christine A Bowen, Cynthia R. Giver, Sara Bitarafan, Hai Minh Nguyen, Tianwen Gao, Michael J. Chen, Ngozi V. Nwabueze, Eric B. Dammer et al. · 2021 · Proceedings of the National Academy of Sciences
  79. Synaptic density in carriers of C9orf72 mutations: a [<sup>11</sup>C]UCB‐J PET study
    Malpetti, Maura, Holland, Negin, Jones, P. Simon, Ye, Rong, Cope, Thomas E., Fryer, Tim D., Hong, Young T., Savulich, George, Rittman, Timothy, Passamonti, Luca et al. · 2021 · Annals of Clinical and Translational Neurology
  80. Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
    Pádua, Mafalda Soares, Guil-Guerrero, José L., Prates, José A. M., Lopes, Paula Alexandra · 2024 · International Journal of Molecular Sciences
  81. RETRACTED ARTICLE: VPS35 regulates tau phosphorylation and neuropathology in tauopathy
    Alana N. Vagnozzi, Jian-Guo Li, Jin Chiu, Roshanak Razmpour, Rebecca Warfield, Servio H. Ramirez, Domenico Praticò · 2019 · Molecular Psychiatry · Retracted
  82. Insight into the emerging and common experimental in-vivo models of Alzheimer’s disease
    Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, Dibbanti HariKrishnaReddy · 2023 · Laboratory Animal Research
  83. The Role of Inflammation in Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis
    Justyna Fołta, Zuzanna Rzepka, Dorota Małgorzata Wrześniok · 2025 · International Journal of Molecular Sciences
  84. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer’s disease
    Renato X. Santos, Sónia C. Correia, Susana Cardoso, Cristina Carvalho, Maria S. Santos, Paula Isabel Moreira · 2011 · Journal of Neurochemistry
  85. Proteasome Inhibition Drives HDAC6-Dependent Recruitment of Tau to Aggresomes
    Chris R. Guthrie, Brian C. Kraemer · 2011 · Journal of Molecular Neuroscience
  86. Neurodegenerative Disorder FTDP-17–Related Tau Intron 10 +16C→T Mutation Increases Tau Exon 10 Splicing and Causes Tauopathy in Transgenic Mice
    Tomohiro Umeda, Takenari Yamashita, Tetsuya Kimura, Kiyouhisa Ohnishi, Hiroshi Takuma, Tomoko Ozeki, Akihiko Takashima, Takami Tomiyama, Hiroshi Mori · 2013 · American Journal Of Pathology
  87. Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies
    Kurt R. Brunden, Carlo Ballatore, Virginia M.‐Y. Lee, Amos B. Smith, John Q. Trojanowski · 2012 · Biochemical Society Transactions
  88. Transcriptional Networks of Microglia in Alzheimer’s Disease and Insights into Pathogenesis
    Gabriel Chew, Enrico G. Petretto · 2019 · Genes
  89. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses
    Sonia Podvin, Alexander Curtis Jones, Qing Liu, Brent D. Aulston, Linnea Ransom, Janneca Ames, Gloria Shen, Christopher B. Lietz, Zhenze Jiang, Anthony John O’Donoghue et al. · 2020 · Molecular & Cellular Proteomics
  90. Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice
    Britschgi, Markus, Takeda-Uchimura, Yoshiko, Rockenstein, Edward, Johns, Hudson, Masliah, Eliezer, Wyss-Coray, Tony · 2012 · Journal of Neuroinflammation
  91. P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies
    Caterina Di Lauro, Carolina Bianchi, Álvaro Sebastián‐Serrano, Lucía Soria-Tobar, Beatriz Alvarez‐Castelao, Annette Nicke, Miguel Dı́az-Hernández · 2021 · Progress in Neurobiology
  92. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy
    Ono, Maiko, Komatsu, Masaaki, Ji, Bin, Takado, Yuhei, Shimojo, Masafumi, Minamihisamatsu, Takeharu, Warabi, Eiji, Yanagawa, Toru, Matsumoto, Gen, Aoki, Ichio et al. · 2022 · Aging Cell
  93. Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome
    Thelma Akanchise, Angelina Angelova · 2023 · Antioxidants
  94. Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging
    Rui Guo, Jianping Liu, Xia Min, Wen Zeng, Bing Shan, Mengmeng Zhang, Zhuohao He, Yaoyang Zhang, Kaiwen He, Junying Yuan et al. · 2024 · Nature Structural & Molecular Biology
  95. Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration
    Maura Malpetti, Peter Swann, Kamen A. Tsvetanov, Leonidas Chouliaras, Alexandra Strauss, Tanatswa Chikaura, Alexander G. Murley, Nicholas James Ashton, Peter B. Barker, Peter Simon Jones et al. · 2024 · Brain
  96. The Role of Reelin Signaling in Alzheimer’s Disease
    Nan‐Nan Yu, Meng‐Shan Tan, Jin‐Tai Yu, Anmu Xie, Lan Tan · 2015 · Molecular Neurobiology
  97. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update
    Kelly R. Bales · 2012 · Expert Opinion on Drug Discovery
  98. Activin as an anti-inflammatory cytokine produced by microglia
    Shuei Sugama, Takato Takenouchi, Hiroshi Kitani, Masayo Fujita, Makoto Hashimoto · 2007 · Journal of Neuroimmunology
  99. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies
    Norbert Žilka, Miroslava Korenova, Michal Novák · 2009 · Acta Neuropathologica
  100. Prostaglandin J2: a potential target for halting inflammation‐induced neurodegeneration
    Maria E. Figueiredo‐Pereira, Chuhyon Corwin, John W. Babich · 2016 · Annals of the New York Academy of Sciences